EVOGENE LTD
EVGNNASDAQ🏆 #3695 by market capUS Equity
$432.19▲ $6.48 (+1.50%)
Simulated price1h—
24h▲ 1.5%
7d—
14d—
30d—
1y—
🏦Market Cap
$11M
Small Cap
📈Revenue Growth (YoY)
+331.5%
High Growth
📊Gross Margin
71.0%
High
💵FCF Margin
—
⚖️P/S Ratio
5.3x
Fair
Otter Score
55
Weak
No chart data available for EVGN.
Trading Snapshot
- Day Range
- $428.78 – $438.07
- 52-Week Range
- $0.37 – $1.50
- Volume
- $2.61B
- Avg Volume
- $3.26B
- Shares Outstanding
- 13.6M
- Next Earnings
- Sep 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $558,440
- P/E Ratio
- —
- P/S Ratio
- 5.3x
- EPS (TTM)
- $-1.38
- Dividend Yield
- —
Why Investors Own EVGN
- ✓High-growth profile — revenue up +25.2% YoY with expanding US Equity exposure.
- ✓Healthy economics — 66% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$2M▲ +25.3% YoY
Gross Margin (TTM)
66.2%▲ +4.0% YoY
Operating Income (TTM)
$595,039▲ +25.3% YoY
Free Cash Flow (TTM)
$193,440▲ +25.3% YoY
About EVOGENE LTD
A company profile for EVOGENE LTD isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
55/100
Analyst Price Target
ⓘAverage Target
$574.65
▲ +33.0% Upside
High Target$705.35
Low Target$517.07
Based on 13 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
EVOGENE LTD tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift EVGN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
EVOGENE LTD announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.